Edition:
United States

AtriCure Inc (ATRC.OQ)

ATRC.OQ on NASDAQ Stock Exchange Global Market

21.65USD
22 May 2017
Change (% chg)

$0.15 (+0.70%)
Prev Close
$21.50
Open
$21.48
Day's High
$21.82
Day's Low
$21.48
Volume
54,449
Avg. Vol
74,590
52-wk High
$23.80
52-wk Low
$13.49

ATRC.OQ

Chart for ATRC.OQ

About

AtriCure, Inc. is an atrial fibrillation (Afib) solutions company. The Company develops, manufactures, and sells devices designed primarily for the surgical ablation of cardiac tissue and systems designed for the exclusion of the left atrial appendage. It has various product lines for the ablation of cardiac tissue, including... (more)

Overall

Beta: 0.81
Market Cap(Mil.): $734.94
Shares Outstanding(Mil.): 33.95
Dividend: --
Yield (%): --

Financials

  ATRC.OQ Industry Sector
P/E (TTM): -- 31.06 17.37
EPS (TTM): -1.06 -- --
ROI: -14.27 12.87 -5.89
ROE: -19.77 15.33 -5.30

BRIEF-Atricure Inc reports Q1 loss per share $0.32

* Q1 earnings per share view $-0.35 -- Thomson Reuters I/B/E/S

May 04 2017

BRIEF-Atricure names two new members to its board of directors

* Regina Groves and B. Kristine Johnson have been appointed to its board of directors

Mar 21 2017

BRIEF-Atricure Q4 loss per share $0.27

* Atricure reports fourth quarter and full year 2016 financial results

Feb 28 2017

BRIEF-Atricure announces preliminary results

* Atricure announces preliminary results for fourth quarter and full year 2016

Feb 03 2017

BRIEF-Hudson Executive Capital reports 5.6 pct stake in AtriCure

* Hudson Executive Capital reports 5.6 pct stake In AtriCure Inc as of Jan 17 - sec filing

Jan 24 2017

BRIEF-AtriCure announces preliminary results for Q4 and FY 2016

* AtriCure announces preliminary results for fourth quarter and full year 2016

Jan 09 2017

More From Around the Web

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $127.26 +0.26
St Jude Medical Inc (STJ.N) -- --

Earnings vs. Estimates